{"id":3107,"date":"2023-10-10T06:00:07","date_gmt":"2023-10-10T11:00:07","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=3107"},"modified":"2023-10-04T12:37:10","modified_gmt":"2023-10-04T17:37:10","slug":"fda-adds-new-warnings-to-the-label-of-tepezza","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/","title":{"rendered":"FDA Adds New Warnings to the Label of TEPEZZA"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-3109\" src=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg\" alt=\"eye-321961_1280-e1696438901920\" width=\"711\" height=\"400\" srcset=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg 711w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920-300x169.jpg 300w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920-213x120.jpg 213w\" sizes=\"(max-width: 711px) 100vw, 711px\" \/>The Food and Drug Administration recently updated the <a href=\"https:\/\/www.ophthalmologytimes.com\/view\/fda-adds-hearing-loss-and-impairment-warnings-to-tepezza-label\" target=\"_blank\" rel=\"noopener\">warning label<\/a> on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor recent changes\u201d for warnings and precautions is \u201chearing impairment including hearing loss.\u201d\u00a0 Hearing loss is just one of four warnings. The others are hyperglycemia, exacerbation of preexisting inflammatory bowel disease and infusion reactions. If you suffered hearing loss or other harm, you should call the trusted Chicago-based dangerous drug lawyers of Moll Law Group. Billions have been recovered in lawsuits around the country with which we\u2019ve been involved.<\/p>\n<p><strong>Call Moll Law Group About a TEPEZZA Claim<\/strong><\/p>\n<p>Tepezza is a drug prescribed to improve symptoms of thyroid eye disease, which is a rare condition in which fatty tissue and muscles located behind the eye become inflamed such that the eye is pushed to the front and bulge outwards. The drug is supposed to mitigate the effects of double vision, proptosis, and chronic bulging eye. Unfortunately it is a drug that carries significant risks.<\/p>\n<p>The new Tepezza warning provides that it can cause serious hearing impairment including hearing loss that could be permanent. Doctors are advised to evaluate a patient\u2019s hearing before, during and after treatment with the drug and also weight the risks and benefits of treating a patient with the drug. The warning came a little less than a month after the Brazilian Health Regulatory Agency approved its use as a thyroid eye disease treatment.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#more-3107\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor recent changes\u201d for warnings and precautions is \u201chearing impairment including hearing loss.\u201d\u00a0 Hearing loss is just one of four warnings. The others are hyperglycemia, exacerbation of preexisting inflammatory bowel disease and infusion [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3109,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4,3],"tags":[],"class_list":["post-3107","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceuticals","category-product-liability"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA Adds New Warnings to the Label of TEPEZZA &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; October 10, 2023<\/title>\n<meta name=\"description\" content=\"The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor &#8212; October 10, 2023\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA Adds New Warnings to the Label of TEPEZZA &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; October 10, 2023\" \/>\n<meta name=\"twitter:description\" content=\"The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor &#8212; October 10, 2023\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Adds New Warnings to the Label of TEPEZZA &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; October 10, 2023","description":"The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor &#8212; October 10, 2023","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/","twitter_card":"summary_large_image","twitter_title":"FDA Adds New Warnings to the Label of TEPEZZA &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; October 10, 2023","twitter_description":"The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor &#8212; October 10, 2023","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"FDA Adds New Warnings to the Label of TEPEZZA","datePublished":"2023-10-10T11:00:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/"},"wordCount":541,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg","articleSection":["Pharmaceuticals","Product Liability"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/","url":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/","name":"FDA Adds New Warnings to the Label of TEPEZZA &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; October 10, 2023","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg","datePublished":"2023-10-10T11:00:07+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"The Food and Drug Administration recently updated the warning label on Horizon Pharmaceutical\u2019s TEPEZZA. The label now includes that one of the \u201cmajor &#8212; October 10, 2023","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg","width":711,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/fda-adds-new-warnings-to-the-label-of-tepezza\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA Adds New Warnings to the Label of TEPEZZA"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2023\/10\/eye-321961_1280-e1696438901920.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=3107"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3107\/revisions"}],"predecessor-version":[{"id":3110,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/3107\/revisions\/3110"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/3109"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=3107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=3107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=3107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}